The effects of perhexiline maleate on low density lipoprotein processing and cholesterol metabolism in cultured human fibroblasts.
The effects of perhexiline maleate (PM, Pexid) on low density lipoprotein (LDL) processing and cholesterol metabolism were investigated after a 24 h pretreatment with the drug. Perhexiline maleate increased LDL uptake in the range 10(-6) to 10(-5) M (180% of control for 10(-5) M), whereas LDL binding and degradation were not affected. Sterol synthesis from sodium acetate was enhanced by perhexiline maleate (X 2.2 for 10(-5) M), while cholesterol esterification with oleic acid was decreased (40% of control for 10(-5) M). These effects of perhexiline on cholesterol metabolism are specific, since the synthesis of triacylglycerols from sodium acetate is not affected and since the incorporation of oleic acid into triacylglycerols is much less impaired. The decreased cholesterol esterification is accompanied by a reduction of acylcoenzyme A-cholesterol-O-acyltransferase (ACAT) activity measured in vitro on cell extracts.
Candide
C
C
Faculté de Médecine Saint-Antoine, Laboratoire de Chimie Biologique, Paris, France.
Mazière
J C
JC
Mazière
C
C
Lageron
A
A
Polonovski
J
J
D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL / Q000378:metabolism*; D010480:Perhexiline / Q000031:analogs & derivatives* / Q000494:pharmacology; D002785:Sterol O-Acyltransferase / Q000378:metabolism
D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL; D002784:Cholesterol; D002785:Sterol O-Acyltransferase; C023470:perhexiline maleate; D010480:Perhexiline